Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accumulated Expenses (2020 - 2025)

iSpecimen has reported Accumulated Expenses over the past 6 years, most recently at $619242.0 for Q4 2025.

  • Quarterly results put Accumulated Expenses at $619242.0 for Q4 2025, down 47.02% from a year ago — trailing twelve months through Dec 2025 was $619242.0 (down 47.02% YoY), and the annual figure for FY2025 was $619242.0, down 47.02%.
  • Accumulated Expenses for Q4 2025 was $619242.0 at iSpecimen, down from $716878.0 in the prior quarter.
  • Over the last five years, Accumulated Expenses for ISPC hit a ceiling of $1.7 million in Q1 2024 and a floor of $7510.0 in Q3 2021.
  • Median Accumulated Expenses over the past 5 years was $882274.0 (2023), compared with a mean of $813949.2.
  • Biggest five-year swings in Accumulated Expenses: tumbled 99.78% in 2021 and later soared 18649.09% in 2022.
  • iSpecimen's Accumulated Expenses stood at $8167.0 in 2021, then soared by 18649.09% to $1.5 million in 2022, then rose by 0.61% to $1.5 million in 2023, then decreased by 24.13% to $1.2 million in 2024, then plummeted by 47.02% to $619242.0 in 2025.
  • The last three reported values for Accumulated Expenses were $619242.0 (Q4 2025), $716878.0 (Q3 2025), and $645567.0 (Q2 2025) per Business Quant data.